The Latest Headlines at American Banking and Market News
-inc-logo-1200x675.PNG?v=20210312142656&w=240&h=220&zc=2){kind=logo}
TELUS International (Cda) Inc. (NYSE:TIXT) Given Average Recommendation of “Hold” by Analysts
TELUS International (Cda) Inc. (NYSE:TIXT – Get Free Report) has been given a consensus recommendation of “Hold” by the fourteen analysts that are presently covering the company, MarketBeat reports. Eight investment... More of this article »
Travere Therapeutics, Inc. (NASDAQ:TVTX) Receives Average Recommendation of “Moderate Buy” from Analysts
Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) has been given an average rating of “Moderate Buy” by the fifteen analysts that are covering the company, Marketbeat Ratings reports. Six equities research... More of this article »
Ball Co. (NYSE:BALL) Given Consensus Rating of “Hold” by Analysts
Ball Co. (NYSE:BALL – Get Free Report) has been given a consensus recommendation of “Hold” by the thirteen research firms that are presently covering the company, Marketbeat.com reports. One investment analyst has... More of this article »
Annaly Capital Management, Inc. (NYSE:NLY) Given Average Rating of “Moderate Buy” by Brokerages
Shares of Annaly Capital Management, Inc. (NYSE:NLY – Get Free Report) have earned an average recommendation of “Moderate Buy” from the seven research firms that are currently covering the company, MarketBeat Ratings... More of this article »
Duolingo, Inc. (NASDAQ:DUOL) Given Consensus Recommendation of “Hold” by Brokerages
Duolingo, Inc. (NASDAQ:DUOL – Get Free Report) has been given a consensus recommendation of “Hold” by the eleven ratings firms that are presently covering the stock, MarketBeat.com reports. One equities research... More of this article »
Riskified Ltd. (NYSE:RSKD) Receives Average Recommendation of “Hold” from Brokerages
Riskified Ltd. (NYSE:RSKD – Get Free Report) has been assigned an average rating of “Hold” from the eight ratings firms that are presently covering the firm, MarketBeat Ratings reports. Six equities research analysts... More of this article »
BRP Inc. (TSE:DOO) Given Average Rating of “Moderate Buy” by Analysts
Shares of BRP Inc. (TSE:DOO – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twelve analysts that are covering the stock, MarketBeat.com reports. Three research analysts... More of this article »
Fair Isaac Co. (NYSE:FICO) Given Average Rating of “Moderate Buy” by Brokerages
Fair Isaac Co. (NYSE:FICO – Get Free Report) has been given an average recommendation of “Moderate Buy” by the nine brokerages that are presently covering the company, Marketbeat Ratings reports. One investment analyst... More of this article »
Shell plc (NYSE:SHEL) Given Average Rating of “Hold” by Brokerages
Shell plc (NYSE:SHEL – Get Free Report) has been assigned a consensus rating of “Hold” from the three research firms that are presently covering the firm, Marketbeat.com reports. Two analysts have rated the stock... More of this article »
Kura Oncology, Inc. (NASDAQ:KURA) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eight analysts that are covering the stock, MarketBeat Ratings reports. One research... More of this article »
Choice Properties Real Est Invstmnt Trst (TSE:CHP.UN) Receives Average Recommendation of “Moderate Buy” from Analysts
Shares of Choice Properties Real Est Invstmnt Trst (TSE:CHP.UN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six analysts that are currently covering the firm, Marketbeat.com... More of this article »
United Therapeutics Co. (NASDAQ:UTHR) Receives Average Rating of “Moderate Buy” from Analysts
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the nine ratings firms that are presently covering the firm, MarketBeat Ratings reports.... More of this article »
Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of “Hold” by Analysts
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has received an average rating of “Hold” from the five analysts that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock... More of this article »